The current valuation score of Harrow Inc is 9.49, ranking 16 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -99.90, which is -89.02% below the recent high of -10.97 and -320.54% above the recent low of -420.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.